Longitudinal Body Composition Assessment in Breast Cancer Patients

Recruiting now

Conditions studied: Breast Neoplasms, Body Composition, Sarcopenia, Fat Redistribution, Lymphedema

In brief

This observational cohort study aims to track longitudinal changes in body composition, including skeletal muscle mass and fat distribution, in patients diagnosed with breast cancer. Following primary surgery and adjuvant therapy, participants will be monitored over a 2-year period. The primary objective is to evaluate the natural progression of skeletal muscle mass index (SMI) and metabolic changes in this population. By conducting serial measurements, this study seeks to characterize the longitudinal trends in muscle loss and body composition shifts post-treatment, providing data to better understand the physiological impact of the cancer recovery process.

Key facts

Study ID: NCT07472803
Run by: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
People needed: 100
Starts: 2025-05-19
Expected to finish: 2027-12-31
Last updated by the study team: 2026-03-16

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

>18 years of age
Diagnosed with stage I-III non-metastatic breast cancer within 12 months of diagnosis
Scheduled for surgery, chemotherapy, with or without radiotherapy or targeted therapy.

You may not qualify if…

Women diagnosed with metastatic (stage IV) breast cancer
Women planning to move away from the area or be away for more than 6 months during the study period
Women planning to become pregnant during the study period
Implantable devices (e.g., pacemaker, nerve stimulator) or surgical implants (e.g., total hip or knee replacements)

Where it is running

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation — New Taipei City, Xindian Dist, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.